Sponsors

Altasciences receives accreditation from College of American Pathologists

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Altasciences’ clinical site in Los Angeles, California, based on results of a recent on-site inspection.

Altasciences was advised of this national recognition and congratulated for the excellence of the services being provided. Altasciences’ Los Angeles site is one of more than 8,000 CAP-accredited facilities worldwide.

“This prestigious accreditation is a testament to the high-quality work and oversight by Altasciences’ dedicated and passionate team in Los Angeles. We are pleased to give our clients the peace of mind that comes with working with a CAP-accredited biorepository, and are proud to have a seal of approval that reflects the quality of our work,” stated Dr David Nguyen, General Manager and Medical Director at Altasciences’ Los Angeles site.

The CAP, first in the industry to offer an accreditation program for biorepositories, based the Biorepository Accreditation Program on the principles of its Laboratory Accreditation Program. The US federal government recognises the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal to, or more stringent than, the government’s own inspection programme. Currently, there is no federal mandate for biorepository accreditation.

The CAP Biorepository Accreditation Program, a three-year accreditation cycle, includes on-site inspection, desk review, and optional education modules and gap assessment. As part of the on-site inspection, the CAP uses accreditation checklists to provide a comprehensive, up-to-date blueprint of quality practices to assist biorepositories in improving their operations and ensure quality. Further, a desk review offers a remote review of a biorepository’s quality management plan, certain procedures, and select quality and process statistics. The programme is designed to ensure the highest standard of patient care.

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. Learn more at www.altasciences.com.

Latest Issues

ECP 2026 - 38th European Congress of Pathology

Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026

UK NEQAS Parasitology Symposium

UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026